MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies

  • MaxCyte and Ori Biotech successfully integrate their ExPERT\u2122 and IRO\u00ae platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines MaxCyte and Ori Biotech successfully integrate their ExPERT\u2122 and IRO\u00ae platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines